Bolt Biotherapeutics (BOLT) Long-Term Investments (2021 - 2025)
Historic Long-Term Investments for Bolt Biotherapeutics (BOLT) over the last 5 years, with Q3 2025 value amounting to $6.9 million.
- Bolt Biotherapeutics' Long-Term Investments fell 7742.99% to $6.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.9 million, marking a year-over-year decrease of 7742.99%. This contributed to the annual value of $22.9 million for FY2024, which is 1337.6% down from last year.
- According to the latest figures from Q3 2025, Bolt Biotherapeutics' Long-Term Investments is $6.9 million, which was down 7742.99% from $13.7 million recorded in Q2 2025.
- In the past 5 years, Bolt Biotherapeutics' Long-Term Investments registered a high of $85.3 million during Q4 2021, and its lowest value of $6.9 million during Q3 2025.
- Its 5-year average for Long-Term Investments is $36.4 million, with a median of $30.6 million in 2024.
- Per our database at Business Quant, Bolt Biotherapeutics' Long-Term Investments surged by 4988.69% in 2022 and then crashed by 7742.99% in 2025.
- Over the past 5 years, Bolt Biotherapeutics' Long-Term Investments (Quarter) stood at $85.3 million in 2021, then plummeted by 71.95% to $23.9 million in 2022, then rose by 10.32% to $26.4 million in 2023, then fell by 13.38% to $22.9 million in 2024, then crashed by 69.82% to $6.9 million in 2025.
- Its last three reported values are $6.9 million in Q3 2025, $13.7 million for Q2 2025, and $19.1 million during Q1 2025.